Stay updated on TransCon IL-2 β/γ Clinical Trial
Sign up to get notified when there's something new on the TransCon IL-2 β/γ Clinical Trial page.

Latest updates to the TransCon IL-2 β/γ Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History shows the addition of revision v3.3.2 and the removal of revision v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page shows routine version history updates: addition of Revision v3.3.1 and removal of Revision v3.2.0 to the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved a site-wide notice about potential delays due to funding and operating status, which does not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedDifference0.1%

- Check72 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference10%

- Check79 days agoChange DetectedThe page has updated the software version from v3.0.2 to v3.1.0. If there were more content changes, they would be evaluated, but here only the version identifier has changed.SummaryDifference0.2%

Stay in the know with updates to TransCon IL-2 β/γ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TransCon IL-2 β/γ Clinical Trial page.